Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3) > Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3):274-85

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Rivista di Dermatologia e Malattie Sessualmente Trasmesse


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

REVIEW  PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF SKIN CANCER PATIENTS


Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3):274-85

DOI: 10.23736/S0392-0488.17.05558-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Melanoma and pregnancy

Camilla SALVINI 1 , Federica SCARFÌ 2, Caterina FABRONI 1, Franca TAVITI 1

1 Unit of Dermatology, USL Toscana Centro-Prato Hospital, Prato, Italy; 2 Unit of Dermatology, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy


PDF  


The last decades were characterized by a worldwide increasing incidence in melanoma. Almost 35% of diagnosed with melanoma women are in childbearing age. Malignant melanoma is the most common malignancy during pregnancy. Considering this background it is clear how melanoma and pregnancy has becoming one of the main topic of discussion. Current knowledge about pregnancy and melanoma is characterized by many controversies and divergences. The real incidence of melanoma in childbearing and the impact of pregnancy on the prognosis of melanoma is still unclear. There are many uncertainties regarding other aspects of women with melanoma during childbearing, such as the changing in moles, the prognosis and the management. Every changing nevus that would raise concern for malignancy in a pregnant patient should be investigated and surgery should be performed safely using local anesthetic. Pregnancy can affect the staging and treatment of melanoma especially in advanced stage, the decision about introduction or continuation of treatment in the event of pregnancy should be preceded by an analysis of the potential benefits and risks. The role of hormonal changes during pregnancy on melanoma is continually debated. At present, there is a lack of a European guideline on this topic and this review aims to address the most controversial issues such as the roles of hormones, staging and therapeutic difficulties of melanoma during pregnancy. The authors’ aim is to help the clinician in the difficult decision-making process concerning the woman suffering from melanoma and her child.


KEY WORDS: Melanoma - Pregnancy - Hormone replacement therapy - Contraceptives, oral - Prognosis - Nevus

inizio pagina

Publication History

Issue published online: April 13, 2017
Article first published online: January 24, 2017

Per citare questo articolo

Salvini C, Scarfì F, Fabroni C, Taviti F. Melanoma and pregnancy. G Ital Dermatol Venereol 2017;152:274-85. DOI: 10.23736/S0392-0488.17.05558-4

Corresponding author e-mail

camilla.salvini@ulscentro.toscana.it